Search - tctmd.com

Displaying 61 - 80 of 138

Sort: Relevancy | Date

News Daily News

Report Provides Snapshot of Initial Commercial TAVR Experience

November 30, 2015

News Daily News

La Complejidad de la ECA No Influye en la Dominación de los SLF Nuevos vs. Viejos

November 16, 2015

News Daily News

CAD复杂性不影响新一代DES相对于较早DES的优越性

November 16, 2015

News Daily News

CAD Complexity Does Not Affect Dominance of Newer vs Older DES

November 16, 2015

The Mayo Clinic Philosophy

Presentation TCT 2015

The Mayo Clinic Philosophy

Presenter: David O. Williams, David R. Holmes Jr.

October 12, 2015

News Conference News TCT 2015

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

October 12, 2015

Comprehensive Analysis of the Watchman Data: PROTECT AF, CAP, and PREVAIL

Presentation TCT 2015

Comprehensive Analysis of the Watchman Data: PROTECT AF, CAP, and PREVAIL

Presenter: Reda Ibrahim, Matthew J. Price, David R. Holmes Jr.

October 11, 2015

Are Ablation and LAA Closure Complementary Approaches in the Patient With Paroxysmal AF With Moderate Stroke Risk?

Presentation TCT 2015

Are Ablation and LAA Closure Complementary Approaches in the Patient With Paroxysmal AF With Moderate Stroke Risk?

Presenter: David R. Holmes Jr., Vivek Y. Reddy, DJ Lakkireddy

October 11, 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presentation TCT 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Saibal Kar

October 11, 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presentation TCT 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Saibal Kar

October 11, 2015

Shades of Gray? Defining the Range of Patients Contraindicated for Anticoagulation

Presentation TCT 2015

Shades of Gray? Defining the Range of Patients Contraindicated for Anticoagulation

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Piera Capranzano

October 11, 2015

Surgical LAA Closure: Patient Selection and Supporting Data

Presentation TCT 2015

Surgical LAA Closure: Patient Selection and Supporting Data

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Michael Argenziano

October 11, 2015

Outcome of Patients With Atrial Fibrillation and Stent Implantation: Results of the Prospective LASER Registry

Presentation TCT 2015

Outcome of Patients With Atrial Fibrillation and Stent Implantation: Results of the Prospective LASER Registry

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Uwe Zeymer

October 11, 2015

What Are the Management Options for the Patient With AF and DES?

Presentation TCT 2015

What Are the Management Options for the Patient With AF and DES?

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Pascal Vranckx

October 11, 2015

Which NOAC for Which Patient?

Presentation TCT 2015

Which NOAC for Which Patient?

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Christopher B. Granger

October 11, 2015

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

Presentation TCT 2015

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Neal S. Kleiman

October 11, 2015

News Daily News

Un Meta Análisis Revela que Watchman sigue Sin ser Inferior a Warfarina y Da Buenos Resultados de Seguridad

Yael L. Maxwell

June 17, 2015

News Daily News

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Yael L. Maxwell

June 17, 2015

News Daily News

Meta 分析表明 Watchman 依旧不逊于华法林，患者结局良好及安全

Yael L. Maxwell

June 17, 2015

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

Presentation

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

Presenter: David R. Holmes Jr

June 16, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.